Cargando…
The concentration of 12-lipoxygenase in platelet rich plasma as an indication of cancer of the prostate
AIM OF THE STUDY: The aim of this study was to determine whether measuring concentrations of 12-LOX in platelet-rich plasma patients can: 1. Differentiate between the group of patients with prostate cancer and healthy men. 2. Correlate the degree of severity of the disease and the concentration of t...
Autores principales: | Piotrowska, Małgorzata, Szefel, Jarosław, Skrzypczak-Jankun, Ewa, Łysiak-Szydłowska, Wiesława, Szajewski, Mariusz, Aleksandrowicz-Wrona, Ewa, Jankun, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934055/ https://www.ncbi.nlm.nih.gov/pubmed/24592128 http://dx.doi.org/10.5114/wo.2013.37221 |
Ejemplares similares
-
Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer
por: Gondek, Tomasz, et al.
Publicado: (2014) -
Medium-chain triglycerides/long-chain triglycerides versus long-chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia
por: Szefel, Jarosław, et al.
Publicado: (2016) -
Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives
por: PARSAI, SHIREEN, et al.
Publicado: (2014) -
Isolation and characterization of serum albumin from Camelus dromedarius
por: MALIK, AJAMALUDDIN, et al.
Publicado: (2013) -
Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review)
por: Wyganowska-Świątkowska, Marzena, et al.
Publicado: (2019)